Gezieltes Arzneimittelkonjugat, Medikament damit und Verbindung
Anmelder: FUJIFILM Corporation 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP4772197
- Anmeldetag
- 26. August 2024
- Veröffentlichung
- 6. März 2025
- Rechtsraum
- EP
Abstract
Provided are a compound or a salt thereof, including two or more structural moieties M selected from a physiologically active substance moiety and a radioisotope-containing moiety; and a structure represented by General Formula (I); as well as a targeted drug conjugate and a medicine including the same. In this regard, the above-mentioned compound and a salt do not have a phosphor moiety and have at least one group selected from a specific hydrophilic group Pi. <img class="EMIRef" id="58dd2ccc-c22f-4349-9dc4-32aab98b2ab6-ia01" /> In the formula, X<1> to X<3> each represent -O-, -S-, >NR<1>, or >CR<2>R<3>. R<1> to R<3> and R<11> each represent a hydrogen atom or a substituent. n is an integer of 2 or more. * represents a bonding site.
Anmelder
- Firma
- FUJIFILM Corporation
- Land
- 🇯🇵 Japan
Japanischer Konzern, hervorgegangen aus der Fotofilmherstellung, heute aktiv in Bildgebung, Dokumentenlösungen, Materialwissenschaften sowie Diagnostik und Arzneimittelherstellung.
12.204 Patente in unserer Datenbank